Proteins lead the way: JAK inhibitors as a new treatment option in toxic epidermal necrolysis

• Benjamin Klein,
• J. Michelle Kahlenberg,
• Johann E. Gudjonsson

Affiliations

Benjamin Klein

Department of Dermatology, Allergology and Venereology, Leipzig University Medical Center, University of Leipzig

J. Michelle Kahlenberg

Department of Internal Medicine, Division of Rheumatology, University of Michigan

Johann E. Gudjonsson

Department of Internal Medicine, Division of Rheumatology, University of Michigan